Yuquan Wang

Mr. Wang founded, and was President of Frost and Sullivan China, a research and consulting firm focused on helping clients achieve transformational growth. In 1995 he founded Beijing Consultech Pharma., a pharmaceutical consulting and marketing firm which was acquired by Omnicom Group. Mr. Wang is on the board of Cerevast Therapeutics, a company developing a revolutionary treatment for acute ischemic stroke. Mr. Wang’s long and varied experience in the telecom industry has helped him facilitate interaction and cooperation between global carriers and major Chinese telecom carriers. He is a frequent lecturer on technology market trends and marketing in the telecom/internet marketplace. Mr. Wang graduated from Beijing Normal University with a Bachelor of Science degree in Biology.